Groupe la Francaise’s ResMed RMD Stock Holding History

Groupe la Francaise’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.63K	Sell	34 -3	-8%	-$748	﹤0.01%	435
2025 Q4	$8.91K	Buy	37 +15	+68%	+$3.84K	﹤0.01%	429
2025 Q3	$6.02K	Sell	22 -199	-90%	-$54.4K	﹤0.01%	622
2025 Q2	$57K	Buy	221 +17	+8%	+$4.05K	﹤0.01%	405
2025 Q1	$45.4K	Buy	+204	New	+$47.6K	﹤0.01%	409

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Groupe la Francaise's RMD Position: Q1 2026 in Review

Groupe la Francaise reduced its ResMed (RMD) stake by 8.1% in Q1 2026, selling an estimated $748 and leaving 34 shares worth $7.63K. The position accounts for ﹤0.01% of the portfolio, ranked #435.

Groupe la Francaise first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $57K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Groupe la Francaise held 34 shares of ResMed worth $7.63K as of Q1 2026.
Groupe la Francaise sold 3 ResMed shares in Q1 2026, an estimated $748.
ResMed made up ﹤0.01% of Groupe la Francaise's portfolio in Q1 2026, its #435 holding.
Groupe la Francaise first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
Groupe la Francaise's ResMed position peaked at $57K in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.